Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
NEW YORK Merkley + Partners has joined Abbott Laboratories’ roster of agencies with responsibility for creative duties on three anti-cholesterol drugs, sources said.
Sources identified the drugs as Simcor, Niaspan and Trilipix. Merkley is said to have landed the business after a review. Annual account billings are estimated at $70 million.
It was not immediately clear who the incumbent was. The Omnicom Group agency did not return calls. Abbott declined to comment, saying through a representative that “it’s not Abbott’s practice to comment on our marketing strategies, vendors or potential vendors.”
Past major media spending behind the drugs has been modest.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in